Russell Frank Company’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$89.4M Sell
794,999
-90,126
-10% -$9.36M 0.16% 144
2015
Q4
$94.8M Buy
885,125
+75,886
+9% +$8.69M 0.17% 141
2015
Q3
$80.7M Buy
809,239
+60,311
+8% +$6.56M 0.15% 141
2015
Q2
$85.4M Buy
748,928
+163,488
+28% +$19.8M 0.14% 163
2015
Q1
$61.2M Buy
585,440
+114,653
+24% +$12.2M 0.11% 218
2014
Q4
$56.8M Buy
470,787
+107,210
+29% +$14.1M 0.1% 232
2014
Q3
$53.2M Buy
363,577
+346,617
+2,044% +$53.5M 0.09% 246
2014
Q2
$2.83M Buy
16,960
+2,123
+14% +$378K ﹤0.01% 1580
2014
Q1
$2.94M Buy
14,837
+7,779
+110% +$1.47M 0.01% 1579
2013
Q4
$1.34M Buy
7,058
+5,028
+248% +$936K ﹤0.01% 1939
2013
Q3
$344K Sell
2,030
-53,049
-96% -$8.23M ﹤0.01% 2615
2013
Q2
$8.35M Buy
+55,079
New +$7.8M 0.02% 946

Other funds holding CLB

Russell Frank Company's CLB Position: Q1 2016 in Review

Russell Frank Company reduced its Core Laboratories (CLB) stake by 10% in Q1 2016, selling an estimated $9.36M and leaving 794,999 shares worth $89.4M. The position accounts for 0.16% of the portfolio, ranked #144.

Russell Frank Company first reported a position in CLB in Q2 2013 and has held it in 12 quarters since. The position peaked at $94.8M in Q4 2015. 365 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

  • Russell Frank Company held 794,999 shares of Core Laboratories worth $89.4M as of Q1 2016.
  • Russell Frank Company sold 90,126 Core Laboratories shares in Q1 2016, an estimated $9.36M.
  • Core Laboratories made up 0.16% of Russell Frank Company's portfolio in Q1 2016, its #144 holding.
  • Russell Frank Company first reported a position in Core Laboratories in Q2 2013 and has held it in 12 quarters since.
  • Russell Frank Company's Core Laboratories position peaked at $94.8M in Q4 2015.
  • 365 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.